The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
GraphDTA: predicting drug–target binding affinity with graph neural networks
Abstract
Summary: The development of new drugs is costly, time consuming and often accompanied with safety issues. Drug repurposing can avoid the expensive and lengthy process of drug development by finding new uses for already approved drugs. In order to repurpose drugs effectively, it is useful to know which proteins are targeted by which drugs. Computational models that estimate the interaction strength of new drug–target pairs have the potential to expedite drug repurposing. Several models have been proposed for this task. However, these models represent the drugs as strings, which is not a natural way to represent molecules. We propose a new model called GraphDTA that represents drugs as graphs and uses graph neural networks to predict drug–target affinity. We show that graph neural networks not only predict drug–target affinity better than non-deep learning models, but also outperform competing deep learning methods. Our results confirm that deep learning models are appropriate for drug–target binding affinity prediction, and that representing drugs as graphs can lead to further improvements. Availability of implementation: The proposed models are implemented in Python. Related data, pre-trained models and source code are publicly available at https://github.com/thinng/GraphDTA. All scripts and data needed to reproduce the post hoc statistical analysis are available from https://doi.org/10.5281/zenodo.3603523. Supplementary information: Supplementary data are available at Bioinformatics online.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
Comprehensive analysis of kinase inhibitor selectivity
Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., & Zarrinkar, P. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1990 · Cited by 2,409
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
DeepDTA: deep drug–target binding affinity prediction
Öztürk, H., Özgür, A., & Ozkirimli, E. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty593 · Cited by 1,696
Molecular graph convolutions: moving beyond fingerprints
Kearnes, S., McCloskey, K., Berndl, M., Pande, V., & Riley, P. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9938-8 · Cited by 1,631
Protein Kinase Inhibitors: Insights into Drug Design from Structure
Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (2004) · Science · doi:10.1126/science.1095920 · Cited by 1,198
The Drug Repurposing Hub: a next-generation drug library and information resource
Corsello, S. M., Bittker, J. A., Liu, Z., Gould, J., McCarren, P., Hirschman, J. E., Johnston, S. E., Vrcic, A., Wong, B., Khan, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4306 · Cited by 1,015
PROSITE, a protein domain database for functional characterization and annotation
Sigrist, C. J. A., Cerutti, L., de Castro, E., Langendijk-Genevaux, P. S., Bulliard, V., Bairoch, A., & Hulo, N. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp885 · Cited by 858
Tang, J., Szwajda, A., Shakyawar, S., Xu, T., Hintsanen, P., Wennerberg, K., & Aittokallio, T. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400709d · Cited by 645
Large-scale comparison of machine learning methods for drug target prediction on ChEMBL
Mayr, A., Klambauer, G., Unterthiner, T., Steijaert, M., Wegner, J. K., Ceulemans, H., Clevert, D.-A., & Hochreiter, S. (2018) · Chemical Science · doi:10.1039/c8sc00148k · Cited by 584
He, T., Heidemeyer, M., Ban, F., Cherkasov, A., & Ester, M. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0209-z · Cited by 509
ChemMine tools: an online service for analyzing and clustering small molecules
Backman, T. W. H., Cao, Y., & Girke, T. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr320 · Cited by 504
An Overview of Scoring Functions Used for Protein–Ligand Interactions in Molecular Docking
Li, J., Fu, A., & Zhang, L. (2019) · Interdisciplinary Sciences: Computational Life Sciences · doi:10.1007/s12539-019-00327-w · Cited by 434
Graph convolutional networks for computational drug development and discovery
Sun, M., Zhao, S., Gilvary, C., Elemento, O., Zhou, J., & Wang, F. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz042 · Cited by 413
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., O’Meara, M. J., Guo, J. Z., Swaney, D. L., Tummino, T. A., Huettenhain, R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.22.002386 · Cited by 395
Graph Convolutional Neural Networks for Predicting Drug-Target Interactions
Torng, W., & Altman, R. B. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00628 · Cited by 371
Frequent substructure-based approaches for classifying chemical compounds
Deshpande, M., Kuramochi, M., Wale, N., & Karypis, G. (2005) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2005.127 · Cited by 371
Kinnings, S. L., Liu, N., Tonge, P. J., Jackson, R. M., Xie, L., & Bourne, P. E. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100369f · Cited by 231
Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks
Strittmatter, S. M. (2014) · Nature Medicine · doi:10.1038/nm.3595 · Cited by 222
New drugs cost US$2.6 billion to develop
Mullard, A. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4507 · Cited by 217
Hirohara, M., Saito, Y., Koda, Y., Sato, K., & Sakakibara, Y. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2523-5 · Cited by 214
Chu, Y., Kaushik, A. C., Wang, X., Wang, W., Zhang, Y., Shan, X., Salahub, D. R., Xiong, Y., & Wei, D.-Q. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz152 · Cited by 208
Chemi-Net: A Molecular Graph Convolutional Network for Accurate Drug Property Prediction
Liu, K., Sun, X., Jia, L., Ma, J., Xing, H., Wu, J., Gao, H., Sun, Y., Boulnois, F., & Fan, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143389 · Cited by 197
Pharmacogenetics in drug discovery and development: a translational perspective
Roses, A. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2593 · Cited by 174
Cichońska, A., Ravikumar, B., Parri, E., Timonen, S., Pahikkala, T., Airola, A., Wennerberg, K., Rousu, J., & Aittokallio, T. A. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005678 · Cited by 127
Iskar, M., Zeller, G., Zhao, X., van Noort, V., & Bork, P. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.11.010 · Cited by 110
Learning with multiple pairwise kernels for drug bioactivity prediction
Cichońska, A., Pahikkala, T., Szedmák, S., Julkunen, H., Airola, A., Heinonen, M., Aittokallio, T. A., & Rousu, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty277 · Cited by 91
Chu, Y., Shan, X., Chen, T., Jiang, M., Wang, Y., Wang, Q., Salahub, D. R., Xiong, Y., & Wei, D. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa205 · Cited by 90
Le, V., Quinn, T. P., Tran, T., & Venkatesh, S. (2020) · BMC Genomics · doi:10.1186/s12864-020-6652-7 · Cited by 72
Self-citationStachel, S. J., Sanders, J. M., Henze, D. A., Rudd, M., Su, H.-P., Li, Y., Nanda, K. K., Egbertson, M. S., Manley, P. J., Jones, K. L., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5006429 · Cited by 64
Feature Selection for Descriptor Based Classification Models. 2. Human Intestinal Absorption (HIA)
Wegner, J. K., Fröhlich, H., & Zell, A. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034233w · Cited by 58
Linguistic measures of chemical diversity and the “keywords” of molecular collections
Woźniak, M., Wołos, A., Modrzyk, U., Górski, R. L., Winkowski, J., Bajczyk, M. D., Szymkuć, S., Grzybowski, B. A., & Eder, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25440-6 · Cited by 57
Cited by
Artificial intelligence for natural product drug discovery
Mullowney, M. W., Duncan, K. R., Elsayed, S. S., Garg, N., van der Hooft, J. J. J., Martin, N. I., Meijer, D., Terlouw, B. R., Biermann, F., Blin, K., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00774-7 · Cited by 460
Artificial intelligence in cancer target identification and drug discovery
You, Y., Lai, X., Pan, Y., Zheng, H., Vera, J., Liu, S., Deng, S., & Zhang, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00994-0 · Cited by 435
Graph Neural Networks and Their Current Applications in Bioinformatics
Zhang, X.-M., Liang, L., Liu, L., & Tang, M.-J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.690049 · Cited by 397
Interpretable bilinear attention network with domain adaptation improves drug–target prediction
Bai, P., Miljković, F., John, B., & Lu, H. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-022-00605-1 · Cited by 362
Yang, Z., Zhong, W., Zhao, L., & Yu-Chian Chen, C. (2022) · Chemical Science · doi:10.1039/d1sc05180f · Cited by 344
Metadata
- Authors
- Nguyen, T., Le, H., Quinn, T. P., Nguyen, T., Le, T. D., & Venkatesh, S.
- Venue
- Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10-24
- Volume
- 37
- Issue
- 8
- Pages
- 1140-1147
- ISSN
- 1367-4803 (ISSN-L)
- 1367-4811
- OpenAlex
- W3096561213
- Cited by
- 1,220
- References
- 34
- FWCI
- 39.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.